International audienceChronic lung allograft dysfunction (CLAD) is the major limitation of long-term survival after lung transplantation. Chronic lung allograft dysfunction manifests as bronchiolitis obliterans syndrome or the recently described restrictive allograft syndrome. Although numerous risk factors have been identified so far, the physiopathological mechanisms of CLAD remain poorly understood. We investigate here the immune mechanisms involved in the development of CLAD after lung transplantation. We explore the innate or adaptive immune reactions induced by the allograft itself or by the environment and how they lead to allograft dysfunction. Because current literature suggests bronchiolitis obliterans syndrome and restrictive all...
Chronic lung allograft dysfunction (CLAD) was recently introduced as an overarching term mainly to c...
Post-transplant bronchiolitis obliterans, also called bronchiolitis obliterans syndrome, affects up ...
Despite significant medical advances since the advent of lung transplantation, improvements in long-...
International audienceChronic lung allograft dysfunction (CLAD) is the major limitation of long-term...
Chronic lung allograft dysfunction (CLAD) is the major limitation of long-term survival after lung t...
Chronic lung allograft dysfunction (CLAD, an umbrella term which encompasses two subtypes—restrictiv...
Chronic lung allograft dysfunction (CLAD) remains a frequent and troublesome complication after lung...
Although chronic lung allograft dysfunction (CLAD) remains the major life-limiting factor following ...
Chronic lung allograft dysfunction (CLAD) was recently introduced as an overarching term covering di...
Chronic lung allograft dysfunction (CLAD) remains a major hurdle limiting long-term survival post lu...
Lung transplantation (LTx) is the final treatment option for patients suffering from end-stage lung ...
Chronic lung allograft dysfunction (CLAD) is the most common cause of mortality in lung transplant r...
Chronic rejection after organ transplantation is defined as a humoral- and cell-mediated immune resp...
Chronic rejection after organ transplantation is defined as a humoral- and cell-mediated immune resp...
Chronic lung allograft dysfunction is a heterogeneous entity limiting long-term survival after lung ...
Chronic lung allograft dysfunction (CLAD) was recently introduced as an overarching term mainly to c...
Post-transplant bronchiolitis obliterans, also called bronchiolitis obliterans syndrome, affects up ...
Despite significant medical advances since the advent of lung transplantation, improvements in long-...
International audienceChronic lung allograft dysfunction (CLAD) is the major limitation of long-term...
Chronic lung allograft dysfunction (CLAD) is the major limitation of long-term survival after lung t...
Chronic lung allograft dysfunction (CLAD, an umbrella term which encompasses two subtypes—restrictiv...
Chronic lung allograft dysfunction (CLAD) remains a frequent and troublesome complication after lung...
Although chronic lung allograft dysfunction (CLAD) remains the major life-limiting factor following ...
Chronic lung allograft dysfunction (CLAD) was recently introduced as an overarching term covering di...
Chronic lung allograft dysfunction (CLAD) remains a major hurdle limiting long-term survival post lu...
Lung transplantation (LTx) is the final treatment option for patients suffering from end-stage lung ...
Chronic lung allograft dysfunction (CLAD) is the most common cause of mortality in lung transplant r...
Chronic rejection after organ transplantation is defined as a humoral- and cell-mediated immune resp...
Chronic rejection after organ transplantation is defined as a humoral- and cell-mediated immune resp...
Chronic lung allograft dysfunction is a heterogeneous entity limiting long-term survival after lung ...
Chronic lung allograft dysfunction (CLAD) was recently introduced as an overarching term mainly to c...
Post-transplant bronchiolitis obliterans, also called bronchiolitis obliterans syndrome, affects up ...
Despite significant medical advances since the advent of lung transplantation, improvements in long-...